Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00457574
Status:
WITHDRAWN
Last Update Posted:
2013-08-28
First Post:
2007-04-05
Brief Title:
Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas
Sponsor:
Gemin X
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
GEM301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gemin X
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None